Accelerating Research and Development of Next Generation Malaria Vaccines Against Malaria - A Model for Mosquito-Borne Diseases
This grant funds innovative research and development of advanced malaria vaccines, supporting new technologies to create highly effective vaccines for malaria and other mosquito-borne diseases.
Funder: National Institutes of Health
Due Dates (Anticipated): February 2027 (anticipated)
Funding Amounts: Not specified; award ceiling/floor not listed. See program page for updates.
Summary: Supports research and preclinical development of next-generation malaria vaccines, leveraging novel approaches and technologies.
Key Information: This is a forecasted opportunity; details may change—monitor the program page for updates.
Description
The National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, anticipates supporting basic research, discovery, and preclinical development of highly efficacious vaccines targeting malaria and potentially other mosquito-borne diseases. This program encourages innovative vaccine design approaches, such as structure-based immunogen design and combination vaccines, aiming to reduce parasite infection and malaria disease burden. The initiative seeks to leverage recent advances in vaccine technology to accelerate the development of next-generation malaria vaccines.
